Developmental changes in extracellular matrix messenger RNAs in the mouse placenta during the second half of pregnancy: Possible factors involved in the regulation of placental extracellular matrix expression

Biology of Reproduction

Volumn 77, Issue 6, 2007, Pages 923-933

  Arai, Koji Y ^a   Nishiyama, Toshio ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Deciduas; Extracellular matrix; Glucose; Oxygen; Placenta; Pregnancy; TGFB family

Indexed keywords

ACTIVIN; ACTIVIN A; FIBRONECTIN; FOLLISTATIN; GLUCOSE; MESSENGER RNA; MYOSTATIN; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FETUS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPOXIA; IN SITU HYBRIDIZATION; NONHUMAN; NUTRIENT SUPPLY; OXYGEN TENSION; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY;

ACTIVINS; ANIMALS; CELL CULTURE TECHNIQUES; COLLAGEN TYPE I; COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; FEMALE; FETAL DEVELOPMENT; FIBRONECTINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOSE; MICE; MICE, INBRED C57BL; ORGAN SIZE; OXYGEN; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 36649001772     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.107.061382     Document Type: Article

References (54)

1. Harkness MRL, Harkness RD. The growth of collagen in the foetus, placenta and foetal membranes of the rat. J Physiol 1955; 128:225-234.
2. Iwahashi M, Ooshima A, Nakano R. Increase in the relative level of type V collagen during development and ageing of the placenta. J Clin Pathol 1996; 49:916-919.
3. Crouch E, Sage H, Bornstein P. Structural basis for apparent heterogeneity of collagens in human basement membranes: type IV procollagen contains two distinct chains. Proc Natl Acad Sci U S A 1980; 77:745-749.
4. Aplin JD, Foden LJ. A cell spreading factor, abundant in human placenta, contains fibronectin and fibrinogen. J Cell Sci 1982; 58:287-302.
5. Bray BA. Quantification of tissue fibronectin from terminal villi of placenta. Biochem J 1985; 226:811-815.
6. Pöschl E, Schlötzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 2004; 131:1619-1628.
7. Grinnell F, Head JR, Hoffpauir J. Fibronectin and cell shape in vivo: studies on the endometrium during pregnancy. J Cell Biol 1982; 94:597-606.
8. Armant DR, Kaplan HA, Mover H, Lennarz WJ. The effects of hexapeptides on attachment and outgrowth of mouse blastcysts cultured in vitro: evidence for the involvement of the cell recognition tripeptide Arg-Gly-Asp. Proc Natl Acad Sci U S A 1986; 83:6751-6755.
9. Feinberg RF, Kliman HJ, Lockwood CJ. Is oncofetal fibronectin a trophoblast glue for human implantation? Am J Pathol 1991; 138:537-543.
10. Aplin JD, Haigh T, Jones CJP, Church HJ, Vicovac L. Development of cytotrophoblast columns from explanted first-trimester human placental villi: role of fibronectin and integrin α5β1. Biol Reprod 1999; 60:828-838.
11. van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991; 5:2814-2823.
12. Enders AC. A comparative study of the fine structure of the trophoblast in several hemochorial placentas. Am J Anat 1965; 116:29-67.
13. Kirby DR, Bradbury S. The hemo-chorial mouse placenta. Anat Rec 1965; 152:279-281.
14. Georgiadesa P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 2002; 23:3-19.
15. Verrecchia F, Mauviel A. Transforming growth factor-β signaling through the smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002; 118:211-215.
16. Verrecchia F, Chu M, Mauviel A. Identification of novel TGF-β /smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001; 276:17058-17062.
17. Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005; 16:73-78.
18. Jones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-β superfamily expression and actions in the endometrium and placenta. Reproduction 2006; 132:217-232.
19. Mitchell MD, Osepchook CC, Leung KC, McMahon CD, Bass JJ. Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab 2006; 91:1434-1437.
20. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family. J Biol Chem 2000; 275:40788-40796.
21. Arai KY, Tsuchida K, Uehara K, Taya K, Sugino H. Characterization of rat follistatin-related gene (FLRG): effects of estrous cycle stage and pregnancy on its mRNA expression in rat reproductive tissues. Biol Reprod 2003; 68:199-206.
22. Wang HQ, Takebayashi K, Tsuchida K, Nishimura M, Noda Y. Follistatin-related gene (FLRG) expression in human endometrium: sex steroid hormones regulate the expression of FLRG in cultured human endometrial stromal cells. J Clin Endocrinol Metab 2003; 88:4432-4439.
23. Tsuchida K. Activins, myostatin and related TGF-β family members as novel therapeutic targets for endocrine, metabolic and immune disorders. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4:157-166.
24. Caniggia I, Winter JL. Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies - a review. Placenta 2002; 23(suppl A):S47-S57.
25. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, Fisher SJ. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004; 114:744-754.
26. Hernandez-Verdun D. Morphogenesis of the syncytium in the mouse placenta. Cell Tiss Res 1974; 148:381-396.
27. Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, Cross JC. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002; 250:358-373.
28. Chen CP, Aplin JD. Placental extracellular matrix: gene expression, deposition by placental fibroblasts and the effect of oxygen. Placenta 2003; 24:316-325.
29. Chen CP, Yang YC, Su TH, Chen CY, Aplin JD. Hypoxia and transforming growth factor-β1 act independently to increase extracellular matrix production by placental fibroblasts. J Clin Endocrinol Metab 2005; 90:1083-1090.
30. Arai KY, Tsuchida K, Li C, Watanabe G, Sugino H, Taya K, Nishiyama T. Purification of recombinant activin A using the second follistatin domain of follistatin-related gene (FLRG). Protein Expr Purif 2006; 49:78-82.
31. Kwon AH, Inoue T, Ha-Kawa SK. Characterization of the asialoglycoprotein receptor under hypoxic conditions in primary cultured rat hepatocytes. J Nucl Med 2005; 46:321-325.
32. Arai KY, Ohshima K, Watanabe G, Arai K, Uehara K, Taya K. Dynamics of messenger RNAs encoding inhibin/activin subunits and follistatin in the ovary during the rat estrous cycle. Biol Reprod 2002; 66:1119-1126.
33. Saylam C, Ozdemir N, Itil IM, Sendag F, Terek MC. Distribution of fibronectin, laminin and collagen type IV in the materno-fetal boundary zone of the developing mouse placenta. Experimental study. Arch Gynecol Obstet 2002; 266:83-85.
34. Kitaoka M, Iyama K, Ushijima T, Mimata C, Hori H, Abe N, Yoshioka H. Differential expressions of collagen types IV, 111, and I during the development of invasive trophoblasts in rats. Dev Dyn 1996; 207:319-431.
35. Kitaoka M, Iyama K, Yoshioka H, Monda M, Usuku G. Immunohistochemical localization of procollagen types I and I11 during placentation in pregnant rats by type-specific procollagen antibodies. J Histochem Cytochem 1994; 42:1453-1461.
36. Iguchi T, Tani N, Sato T, Fukatsu N, Ohta Y. Developmental changes in mouse placental cells from several stages of pregnancy in vivo and in vitro. Biol Reprod 1993; 48:188-196.
37. Coan PM, Ferguson-Smith AC, Burton GJ. Developmental dynamics of the definitive mouse placenta assessed by stereology. Biol Reprod 2004; 70:1806-1813.
38. Johnson PM, Faulk WP. Immunological studies of human placentae: identification and distribution of proteins in immature chorionic villi. Immunology 1978; 34:1027-1035.
39. Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG. A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-αC and follistatin during pregnancy. Hum Reprod 1998; 13:3530-3536.
40. Arai KY, Tanaka Y, Taniyama H, Tsunoda N, Nambo Y, Nagamine N, Watanabe G, Taya K. Expression of inhibins, activins, insulin-like growth factor-I and steroidogenic enzymes in the equine placenta. Domest Anim Endocrinol 2006; 31:19-34.
41. Muttukrishna S, Fowlert PA, George FL, Groome NP, Knight PG. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab 1996; 81:3328-3334.
42. Kondo M, Kojima C, Watanabe G, Shimizu K, Itoh M, Udono T, Taya K. Endocrinologic comparison of activin A secretion during pregnancy and early lactation in Japanese monkeys, chimpanzees, and humans. Endocrine 2003; 22:239-243.
43. Ohshima K, Arai KY, Kishi H, Itoh M, Watanabe G, Terranova PF, Arai K, Uehara K, Groome NP, Taya K. Potential role of activin A in follicular development during the second half of pregnancy in the golden hamster: utero-placental source of activin A. J Endocrinol 2002; 172:247-253.
44. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-β3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999; 103:1641-1650.
45. Massague J, Chen Y. Controlling TGF-beta signalling. Genes Dev 2000; 14:627-644.
46. Geiser AG, Kim SJ, Roberts AB, Sporn MB. Characterization of the mouse transforming growth factor-β1 promoter and activation by the Haras oncogene. Mol Cell Biol 1991; 11:84-92.
47. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, Qiu Y. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 2002; 277:40735-40741.
48. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ. Induction of cachexia in mice by systemically administered myostatin. Science 2002; 296:1486-1488.
49. Feinberg RF, Kliman HJ, Wang CL. Transforming growth factor-β stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo. J Clin Endocrinol Metab 1994; 78:1241-1248.
50. Guller S, Wozniak R, Kong L, Lockwood CJ. Opposing actions of transforming growth Factor-β and glucocorticoids in the regulation of fibronectin expression in the human placenta. J Clin Endocrinol Metab 1995; 80:3273-3278.
51. Lee MJ, Ma Y, LaChapelle L, Kadner SS, Guller S. Glucocorticoid enhances transforming growth factor-β effects on extracellular matrix protein expression in human placental mesenchymal cells. Biol Reprod 2004; 70:1246-1252.
52. Yamashita S, Maeshima A, Kojima I, Nojima Y. Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 2004; 15:91-101.
53. Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 1997; 138:3976-3986.
54. Sato T, Roy S. Effect of high glucose on fibronectin expression and cell proliferation in trabecular meshwork cells. Invest Ophthalmol Vis Sci 2002; 43:170-175.